Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Orion Corporation, Orion Pharma

Clinical trials sponsored by Orion Corporation, Orion Pharma, explained in plain language.

Orion Corporation ORNBV NASDAQ HELSINKI

Orion is a Finnish pharmaceutical company developing and marketing drugs, including for CNS and respiratory diseases.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

Can a new pill outsmart resistant prostate cancer?

Disease control Ongoing

This trial is testing an experimental oral drug called ODM-208 in men with metastatic castration-resistant prostate cancer, a type of prostate cancer that has spread and no longer responds to standard hormone therapy. The main goal is to find the highest safe dose and to assess t…

Phase: PHASE1, PHASE2 • Sponsor: Orion Corporation, Orion Pharma • Aim: Disease control

Last updated Aug 16, 2026 00:00 UTC